Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Schlagbauer-Wadl

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Melanoma Research|September 30, 1999
Mutated N-ras upregulates Bcl-2 in human melanoma in vitro and in SCID miceC Borner, H Schlagbauer Wadl, I Fellay, et al.
Melanoma Research|July 17, 1998
Expression of Bcl-2 family members in human melanocytes, in melanoma metastases and in melanoma cell linesE Selzer, H Schlagbauer-Wadl, I Okamoto, et al.
Molecular Medicine (Cambridge, Mass.)|October 31, 2000
A novel Ras antagonist regulates both oncogenic Ras and the tumor suppressor p53 in colon cancer cellsJ Halaschek-Wiener, V Wacheck, H Schlagbauer-Wadl, et al.
Melanoma Research|November 30, 2000
Erythropoietin receptor expression in human melanoma cellsE Selzer, V Wacheck, R Kodym, et al.
Anticancer Research|August 15, 1998
Technetium-99m-tetrofosmin: a new agent for melanoma imaging?S Meghdadi, G Karanikas, H Schlagbauer-Wadl, et al.
The Journal of Investigative Dermatology|March 25, 2000
Bcl-2 antisense oligonucleotides (G3139) inhibit Merkel cell carcinoma growth in SCID miceH Schlagbauer-Wadl, G Klosner, E Heere-Ress, et al.
European Journal of Clinical Pharmacology|May 11, 2000
Pharmacokinetics and pharmacodynamics of the novel H1-receptor antagonist emedastine in healthy volunteersB Jansen, U Graselli, S Dallinger, et al.
The Journal of Investigative Dermatology|August 21, 2001
Perilesional injection of r-GM-CSF in patients with cutaneous melanoma metastasesC Hoeller, B Jansen, E Heere-Ress, et al.
Melanoma Research|August 2, 2001
Elevated procaspase levels in human melanomaD Fink, H Schlagbauer-Wadl, E Selzer, et al.
Cancer Research|February 1, 1997
Activated N-ras contributes to the chemoresistance of human melanoma in severe combined immunodeficiency (SCID) mice by blocking apoptosisB Jansen, H Schlagbauer-Wadl, H G Eichler, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Melanoma Research|September 30, 1999
Mutated N-ras upregulates Bcl-2 in human melanoma in vitro and in SCID miceC Borner, H Schlagbauer Wadl, I Fellay, et al.
Melanoma Research|July 17, 1998
Expression of Bcl-2 family members in human melanocytes, in melanoma metastases and in melanoma cell linesE Selzer, H Schlagbauer-Wadl, I Okamoto, et al.
Molecular Medicine (Cambridge, Mass.)|October 31, 2000
A novel Ras antagonist regulates both oncogenic Ras and the tumor suppressor p53 in colon cancer cellsJ Halaschek-Wiener, V Wacheck, H Schlagbauer-Wadl, et al.
Melanoma Research|November 30, 2000
Erythropoietin receptor expression in human melanoma cellsE Selzer, V Wacheck, R Kodym, et al.
Anticancer Research|August 15, 1998
Technetium-99m-tetrofosmin: a new agent for melanoma imaging?S Meghdadi, G Karanikas, H Schlagbauer-Wadl, et al.
The Journal of Investigative Dermatology|March 25, 2000
Bcl-2 antisense oligonucleotides (G3139) inhibit Merkel cell carcinoma growth in SCID miceH Schlagbauer-Wadl, G Klosner, E Heere-Ress, et al.
European Journal of Clinical Pharmacology|May 11, 2000
Pharmacokinetics and pharmacodynamics of the novel H1-receptor antagonist emedastine in healthy volunteersB Jansen, U Graselli, S Dallinger, et al.
The Journal of Investigative Dermatology|August 21, 2001
Perilesional injection of r-GM-CSF in patients with cutaneous melanoma metastasesC Hoeller, B Jansen, E Heere-Ress, et al.
Melanoma Research|August 2, 2001
Elevated procaspase levels in human melanomaD Fink, H Schlagbauer-Wadl, E Selzer, et al.
Cancer Research|February 1, 1997
Activated N-ras contributes to the chemoresistance of human melanoma in severe combined immunodeficiency (SCID) mice by blocking apoptosisB Jansen, H Schlagbauer-Wadl, H G Eichler, et al.
Pageof 2